Black Seed (Nigella sativa)

A traditional seed with a broad anti-inflammatory story. Take the whole ground seed, not the oil.

Mechanisms, studies and evidence grades for each claim above.

Whole seed vs. oil

The oil form has a real, specific problem: thymoquinone (TQ) content measured across commercial black seed oil brands ranges from roughly 0.07% to 1.88% — about a 27x spread — with no label test or easy way for a buyer to verify potency before use. (Moderate — based on analytical surveys of commercial products, not a single controlled study) The oil is also 50–60% linoleic acid, adding omega-6/PUFA load that isn't wanted on top of an already LA-heavy diet (see Linoleic Acid & Metabolic Disease).

Whole ground seed at roughly 1 g twice daily matches the dosing actually used in most human clinical trials, so it inherits whatever precedent those trials provide. The oil doesn't have the same trial precedent behind its typical consumer dosing.

Verdict: whole ground seed > oil, for dosing precedent and avoiding unverifiable potency and added PUFA.

Thymoquinone (TQ) — the active compound

TQ is the seed's best-characterized bioactive constituent. Preclinical work — mouse and cell-line studies — reports anti-inflammatory, antioxidant, hepatoprotective, cardioprotective, and neuroprotective effects across nearly every organ system studied. (Animal–in-vitro) This is broad and consistent enough to take seriously as a mechanism story, but breadth-across-organ-systems in animal models is exactly the pattern that doesn't reliably survive translation to humans.

Human clinical evidence is real but limited: small-to-medium trials show modest effects on blood sugar, cholesterol, blood pressure, asthma symptoms, and osteoarthritis. (Moderate, effect sizes modest) None of this is dramatic, and none of it is close to the volume of preclinical claims.

TQ has poor oral bioavailability on its own — it needs a fat/lipid carrier to absorb well, which is the practical reason to take it with food that contains some fat rather than on an empty stomach or in water.

Mechanism: NQO1 and NAD⁺ recycling

TQ is a quinone, which makes it a substrate for NQO1 (NAD(P)H quinone oxidoreductase 1) — a riboflavin/FAD-dependent enzyme that catalyzes an obligate two-electron reduction. Two things happen in the same reaction: NADH is oxidized back to NAD⁺, and the quinone substrate is reduced to its hydroquinone form. (Strong — core enzymology, well established) That dual output is the whole appeal: the cell regenerates the oxidized NAD⁺ that Complex I and several TCA-cycle dehydrogenases require to keep running, while the reduced quinone itself becomes a recyclable antioxidant. Going through NQO1 specifically (rather than a one-electron reductase such as cytochrome P450 reductase) matters because two-electron reduction skips the unstable semiquinone radical intermediate that one-electron pathways produce — the reaction most quinone toxicity actually comes from.

TQ isn't the only dietary or supplemental NQO1 substrate that works this way — ubiquinone (CoQ10), PQQ, and beta-lapachone (the naphthoquinone in Pau d'arco) all feed the same enzyme. See Supplements for whether any of those earn their own page.

NQO1 expression itself is controlled upstream by NRF2, the master antioxidant-response transcription factor. Exercise, sulforaphane (cruciferous vegetables), and dietary polyphenols are among the best-supported NRF2 activators (Moderate–Strong for NRF2 activation itself; Inferred that a modest dietary dose of any single quinone substrate meaningfully moves whole-body NAD⁺/NADH balance on top of that) — which puts a ceiling on how much a single quinone-containing seed can be expected to do in isolation, versus supporting the pathway that regulates the enzyme in the first place.

The same mechanism has a dark side worth knowing about: NQO1 is characteristically over-expressed in cancer cells as part of the Warburg effect's need to keep salvaging NAD⁺ under fermentation-heavy metabolism — the same job lactate dehydrogenase does when it reduces pyruvate to lactate (see Cancer as Metabolic Disease, Part IV.1). Several chemotherapy drugs are themselves quinones that exploit this: some (bioreductively activated by NQO1, e.g. mitomycin-C-class agents) get converted into DNA-alkylating species specifically inside NQO1-high tumor cells; others undergo one-electron reduction elsewhere and generate the semiquinone-radical oxidative damage NQO1 normally helps cells avoid. It's the same chemistry in both directions — a two-electron quinone reductase that recycles NAD⁺ and detoxifies quinones at physiological turnover, and an exploitable liability when the substrate load or reaction rate gets pushed high enough. (Animal–in-vitro for the cancer-cell NQO1 overexpression finding; mechanism-level reasoning, not a claim that dietary TQ meaningfully engages this pathway either way)

Breadth of preclinical effects

Preclinical review figures for TQ tend to organize its effects around four core mechanisms that then radiate out into a long list of organ-system claims. Worth seeing the whole shape of it, because the shape itself is informative — both about the strength of the mechanism story and about how much to discount any single claimed effect. (Animal–in-vitro throughout this section unless noted otherwise)

The four core mechanisms

• Oxidative stress: reported to lower MDA, ROS, 4-HNE, and lipid peroxidation while raising the antioxidant enzymes SOD, GPx, CAT, GST, and HO-1 — upstream of NRF2, consistent with the NQO1/NRF2 story above.
• Inflammation: reported to suppress NF-κB and TLR signalling, along with COX2, LOX1, IL-1β, IL-6, TNFα, TGFβ, VCAM1, iNOS, and MMP9.
• Apoptosis: in damaged or cancerous cells, reported to raise BAX, cleaved PARP1, caspase-3/9, and cytochrome-c release while lowering Bcl-2, acting through p38/JNK/ERK signalling — i.e. pushing compromised cells toward programmed death rather than protecting them.
• Immune modulation: reported effects on T- and B-cell proliferation and CD4+ T-cell activation.

A fifth thread — energy metabolism and autophagy (↑AMPK, PPARγ, PGC1α, SIRT1, IGF-1, PI3K/Akt, UCP1, FGF21; ↓HIF-1α) — feeds specifically into the metabolic-disease-adjacent entries below (anti-diabetic, anti-obesity, skin, pulmonary).

Organ-system claims built on those mechanisms

Two honest caveats belong right next to this table, not buried after it. First, a list like this is typically compiled across dozens of separate studies — different species, doses, delivery routes, disease models, and cell lines — not one coherent experiment, so the coherence of the "wheel" is partly an artifact of how review figures get assembled, not evidence that TQ reliably does all of this at once in one animal, let alone one person. Second, the anti-cancer marker list above includes both up- and down-regulated tumor-suppressor and oncogene-adjacent proteins side by side (e.g. Brca1/2 and p53-pathway components appearing alongside proliferation markers) — a reminder that "anti-cancer" summaries like this often mix effects observed in different cancer types and models rather than one clean mechanism, and shouldn't be read as a settled, unified pathway.

Practical use

• Grind fresh, in small batches (roughly a week's worth at a time) — the seed is oil-dense and oxidizes once cracked open. Store the ground seed airtight and away from light.
• Dose: about ½ tsp (~1 g) daily, taken alongside some dietary fat for absorption.
• Delivery: stirred into a smoothie or food is fine — no meaningful absorption advantage to milk versus a smoothie.

No linked citations for the specific figures above (TQ variability range, oil fatty-acid composition, trial dosing, NQO1/NRF2 mechanism, the organ-system effects table) — these are carried over from source notes rather than a numbered reference list. The NQO1 enzymology and NRF2 upstream regulation are well-established biochemistry; the organ-system table is transcribed from a preclinical-review-style summary figure and inherits that figure's sourcing, not a citation checked against the underlying primary studies here. Worth an audit pass to attach PMIDs across all of it, and to verify the review figure's own sourcing while at it.